Cargando…

SARS-CoV-2 Mitochondriopathy in COVID-19 Pneumonia Exacerbates Hypoxemia

Detalles Bibliográficos
Autor principal:	Archer, Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650964/ http://dx.doi.org/10.1016/j.freeradbiomed.2022.10.281

Ejemplares similares

SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia
por: Archer, Stephen L., et al.
Publicado: (2022)

Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies
por: Swerdlow, Russell H.
Publicado: (2009)

Chromium and cobalt intoxication mimicking mitochondriopathy
por: Rattay, Tim W., et al.
Publicado: (2021)

Molecular oncology focus - Is carcinogenesis a 'mitochondriopathy'?
por: Czarnecka, Anna M, et al.
Publicado: (2010)

Severe Hypoxemia in Early COVID-19 Pneumonia
por: Bhatia, Pradeep, et al.
Publicado: (2020)

Management of hypoxemia in SARS-CoV-2 infection: Lessons learned from one year of experience, with a special focus on silent hypoxemia
por: Serrano, Ricardo, et al.
Publicado: (2021)

Zonisamide Ameliorates Microglial Mitochondriopathy in Parkinson’s Disease Models
por: Tada, Satoshi, et al.
Publicado: (2022)

SARS-CoV-2 Pneumonia in Hospitalized Asthmatic Patients Did Not Induce Severe Exacerbation
por: Grandbastien, Manon, et al.
Publicado: (2020)

Alveolar Hyperoxia and Exacerbation of Lung Injury in Critically Ill SARS-CoV-2 Pneumonia
por: Dushianthan, Ahilanandan, et al.
Publicado: (2023)

Severe hypoxemia in a patient with right ventricular myocardial infarction and SARS-CoV-2 infection
por: Albuquerque, Francisco, et al.
Publicado: (2022)

Is Long COVID Syndrome a Transient Mitochondriopathy Newly Discovered: Implications of CPET
por: Sakellaropoulos, Stefanos G., et al.
Publicado: (2022)

Atherosclerosis as Mitochondriopathy: Repositioning the Disease to Help Finding New Therapies
por: Shemiakova, Taisiia, et al.
Publicado: (2021)

Reticular Dysgenesis and Mitochondriopathy Induced by Adenylate Kinase 2 Deficiency with Atypical Presentation
por: Ghaloul-Gonzalez, Lina, et al.
Publicado: (2019)

Radiological findings for diagnosis of SARS-CoV-2 pneumonia (COVID-19)()
por: Sánchez-Oro, Raquel, et al.
Publicado: (2020)

Silent Hypoxemia in Patients with COVID-19 Pneumonia: A Review
por: Guo, Lizhe, et al.
Publicado: (2021)

Cytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathies
por: Wilkins, Heather M., et al.
Publicado: (2014)

Paradoxical Inhibition of Glycolysis by Pioglitazone Opposes the Mitochondriopathy Caused by AIF Deficiency
por: Bénit, Paule, et al.
Publicado: (2017)

SARS-CoV-2 Exacerbates COVID-19 Pathology Through Activation of the Complement and Kinin Systems
por: Savitt, Anne G., et al.
Publicado: (2021)

PATIENT CLINICAL CONDITION IN RELATION TO HYPOXEMIA AND CHEST X-RAY CHANGES IN NOVEL CoV-19 PNEUMONIA: A CASE REPORT
por: Kovačević, Mirza
Publicado: (2021)

MPC2 variants disrupt mitochondrial pyruvate metabolism and cause an early-onset mitochondriopathy
por: Pujol, Claire, et al.
Publicado: (2022)

Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2
por: Yang, Hai-Jun, et al.
Publicado: (2020)

Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2
por: Du, Rong-Hui, et al.
Publicado: (2020)

Prednisolone/rituximab: COVID-19 and SARS-CoV-2 pneumonia: case report
Publicado: (2021)

SARS-CoV-2 and Multiple Sclerosis: Potential for Disease Exacerbation
por: MacDougall, Madison, et al.
Publicado: (2022)

Immunosuppressants: SARS-CoV-2 pneumonia and SARS-CoV-2 infection: 2 case reports
Publicado: (2021)

When success means focusing on the oxygen delivery. A case of conventional management of severe hypoxemia in SARS-CoV-2
por: Franqueza, J.L., et al.
Publicado: (2021)

When success means focusing on the oxygen delivery. A case of conventional management of severe hypoxemia in SARS-CoV-2
por: Franqueza, J.L., et al.
Publicado: (2021)

Biallelic mutations in the ferredoxin reductase gene cause novel mitochondriopathy with optic atrophy
por: Peng, Yanyan, et al.
Publicado: (2017)

Biallelic mutations in the ferredoxin reductase gene cause novel mitochondriopathy with optic atrophy
por: Peng, Yanyan, et al.
Publicado: (2018)

Mitochondriopathy Manifesting as Inherited Tubulointerstitial Nephropathy Without Symptomatic Other Organ Involvement
por: Buglioni, Alessia, et al.
Publicado: (2021)

Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2
por: Yao, Zhixian, et al.
Publicado: (2020)

SARS-CoV-2 infection with pneumonia and encephalitis
por: Hassan, Muhammad, et al.
Publicado: (2021)

Lobar expression of SARS-CoV-2 pneumonia
por: Mendes Pedro, Diogo, et al.
Publicado: (2021)

SARS-CoV-2 infection with pneumonia and stroke
por: Hassan, Muhammad, et al.
Publicado: (2021)

Laboratory Diagnosis of SARS-CoV-2 Pneumonia
por: Gitman, Melissa R., et al.
Publicado: (2021)

SARS-CoV-2 and COVID-19
por: Sheng, Wang-Huei, et al.
Publicado: (2020)

Arrhythmias in COVID-19/SARS-CoV-2 Pneumonia Infection: Prevalence and Implication for Outcomes
por: Denegri, Andrea, et al.
Publicado: (2022)

Detection of SARS-CoV-2 in Hemodialysis Effluent of Patient with COVID-19 Pneumonia, Japan
por: Okuhama, Ayako, et al.
Publicado: (2020)

SARS-CoV-2 neutralizing antibody levels are correlated with severity of COVID-19 pneumonia
por: Chen, Wei, et al.
Publicado: (2020)

COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia
por: Zhou, Yutian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9qcp59pbmgec73tgh8olakl1b1